Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
Interconnected gears representing workflow and data integrity in a lab

Aug 4, 2026

Beyond the Technology: AI Readiness in Regulated Laboratories

AI readiness in regulated laboratories extends beyond mere technological upgrades, emphasizing the importance of integrated workflows and compliance from the start.For laboratories within regulated environments, successful AI implementation hinges on several critical factors. These include creating interconnected workflows, ensuring data integrity, and establishing effective human oversight. Disparate processes can severely hinder AI functionality and pose significant challenges regarding govern
A minimalist representation of a smartphone with a glowing screen against a dark background.

Aug 4, 2026

Denver Life Sciences Wins Two Red Dot Design Awards

Denver Life Sciences has recently garnered two Red Dot Design Awards for its innovative mobile app, recognized in the User Experience and Lifestyle Apps categories. This accolade arrives as the company gears up for its Kickstarter campaign set to launch in 2026.The awards highlight the app's sophisticated design, which aims to simplify complex physiological data into user-friendly insights. CEO Gurbinder Bali emphasized the team's dedication to crafting a visually appealing and functional experi
A petri dish with RNA sequences in a dimly lit lab setting.

Aug 4, 2026

Chinese life sciences AI model GeneLLM emerges as the 'Biological DeepSeek'

China's Jindu Life Science has introduced GeneLLM, a pioneering multi-omics large model, aiming to redefine AI's role in life sciences, akin to DeepSeek.GeneLLM stands out as the first model pre-trained on raw omics data, marking a significant advancement in the field. Developed by a team of scholars from Oxford, this model is designed to interpret complex biological information using RNA sequences as its foundational tokens. By leveraging vast amounts of unprocessed sequencing data, GeneLLM aim
Silhouette of a clinical trial participant with an AI brain icon above

Aug 4, 2026

Icon inks Anthropic partnership to deploy Claude into clinical trials

Icon has partnered with Anthropic to integrate Claude’s AI capabilities into clinical trials, aiming to enhance operational efficiency in drug development.In a significant move to bolster its digital innovation, Icon, a contract research organization, has entered a multi-year collaboration with Anthropic. This partnership will utilize Anthropic’s Life Sciences research team to enhance Icon's agentic AI platform, Orbis. The goal is to improve site intelligence and study planning through advanced
Press release cover image

Aug 4, 2026

Press release

YD Bio Highlights Peer-Reviewed Publication on New Computational Framework for Keratoconus Research

Published in Bioengineering, a collaborative study with Taipei Medical University researchers identifies key molecular candidates to help guide the development of regenerative therapies for corneal disease. TAIPEI, Taiwan, Aug. 04, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation–based cancer detection technology and ophthalmologic innovations, today highlighted the publication of a new peer-reviewed study in
A test tube with a colorful liquid in a dim laboratory setting

Aug 4, 2026

Aiforia secures €20 million for AI-powered cancer diagnostics

Aiforia has successfully secured €20 million in venture debt aimed at advancing its AI-driven cancer diagnostics platform and enhancing its commercial activities.The Helsinki-based life sciences firm obtained this funding from the European Investment Bank (EIB) via the European Commission’s InvestEU program. The financial package is structured in three tranches, starting with an initial €5 million, contingent upon Aiforia meeting specific revenue and performance milestones outlined in the financ
A minimalist representation of global collaboration and communication in a dark palette.

Aug 4, 2026

RWS To Acquire Acolad To Expand European AI And Language Services Platform

RWS has announced its intention to acquire Acolad, a significant player in language and content services, marking a strategic move to enhance its AI and multilingual offerings across Europe.The acquisition, which involves Acolad’s parent company Acogroup, aims to broaden RWS’ client base and leverage Acolad's expertise in localization and AI-powered content solutions. Acolad, based near Paris, employs around 1,200 people across 22 countries and boasts a robust network of over 10,000 linguists an
A regulatory document on a desk in a clinical office setting

Aug 4, 2026

Dassault Systèmes to Acquire ArisGlobal for Life Sciences AI and Compliance Capabilities

Dassault Systèmes has announced its plan to acquire ArisGlobal, a software provider specializing in AI solutions for the life sciences sector, in a deal valued at around $1.8 billion. This acquisition aims to enhance Dassault's offerings in regulatory affairs, pharmacovigilance, and quality management, among other areas, thereby creating a more integrated data environment for managing the entire therapy lifecycle.The acquisition is set to strengthen Dassault Systèmes’ existing life sciences port
Flat design of a medical imaging device silhouette

Aug 4, 2026

Cortechs.ai Expands European CE Marking Across AI Imaging Platform, Accelerating Global Growth

Cortechs.ai has announced an expansion of its European CE Marking for its AI imaging products, reinforcing its commitment to global growth in the medical imaging sector.The company has received CE certification under the European Union Medical Device Regulation for its latest offerings, including the updated NeuroQuant® platform and OnQ™ Prostate. This certification confirms that these products meet stringent EU standards for safety and performance, allowing Cortechs.ai to commercialize its inno
A bioreactor in a biomanufacturing lab, showcasing intricate details and lab equipment in the background.

Aug 4, 2026

NSF-Funded Test Bed Lets Researchers Program Automated Biomanufacturing Workflows

The University of Maryland has received a $17.3 million grant from the National Science Foundation (NSF) to establish a test bed aimed at automating biomanufacturing workflows, enhancing research capabilities in this critical field.The initiative, led by the Collaborative for the Realization of Autonomous Biomanufacturing (CRAB) Lab, is part of a broader NSF investment in programmable laboratory nodes, totaling $400 million. This network is designed to foster AI-enabled laboratories that can inn
A minimalist representation of a rework module in life sciences manufacturing.

Aug 4, 2026

QT9 Updates ERP Software for Life Sciences Manufacturers

QT9 Software has rolled out significant updates to its ERP system tailored for life sciences manufacturers, addressing the complexities of regulated environments while minimizing operational overhead.The updated QT9 ERP platform serves sectors such as medical devices, pharmaceuticals, and biotechnology, integrating various functions like manufacturing, inventory management, and business operations into a cohesive system. Key enhancements include a rework module that facilitates the management of
Press release cover image

Aug 4, 2026

Press release

Bioxytran Leverages Artificial Super Intelligence (ASI) to Design Broad-Spectrum Antiviral and Anti-Cancer Metastasis Drugs

Company's ASI-Powered Carbohydrate Design Platform, in Collaboration with University of Minnesota Department of Chemistry, Represents Paradigm Shift in Rational Drug Discovery Boston Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Bioxytran, Inc. (OTCQB: BIXT), a clinical-stage biotechnology company pioneering innovative therapies for viral diseases and cancer metastasis, today announced the execution of a second Sponsored Research Agreement with the University of Minnesota’s Department of Chemistry